Jeffrey Hull, MD
Otolaryngology · West Plains, MONPI 1033106539
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,816 of the $3,011 with a category attached, or 60.3%. 14 manufacturers reported payments, led by Aerin Medical Inc. at 50.6% of the total. Reporting peaked in 2024 at $1,559 and has fallen 85.9% since, to $219 in 2025.
Across 39 payments — averaging $77.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$2K
- Inspire Medical Systems, Inc.$922
- KARL Storz Endoscopy-america$153
- Sanofi-aventis U.S. LLC$70
- Smith+Nephew$57
- Sanofi$51
- plus $235 from 8 others
What the payments were for
- Travel & lodging$1,81660%
- Food & beverage$1,12437%
- Education$702%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 13 | $1,523 |
| Inspire Medical Systems, Inc. | 3 | $922 |
| KARL Storz Endoscopy-america | 4 | $153 |
| Sanofi-aventis U.S. LLC | 1 | $70 |
| Smith+Nephew | 1 | $57 |
| Sanofi | 3 | $51 |
| Stryker | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 3 | $49 |
| Integra Lifesciences Corporation | 2 | $42 |
| GSK | 2 | $32 |
| Merck | 2 | $26 |
| Greer Laboratories, Inc. | 1 | $14 |
| Optinose US, Inc. | 1 | $12 |
| Novartis | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,011 in reported general payments places this provider in the 75th percentile of 210 otolaryngology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 14 | $52,866 |
| Azelastine Hcl | 103 | $2,647 |
| Ofloxacin | 48 | $2,564 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 24 | $2,429 |
| Fluticasone Propionate | 164 | $1,671 |
| Ipratropium Bromide | 44 | $1,383 |
| Doxycycline Hyclate | 80 | $1,027 |
| Famotidine | 108 | $1,009 |
| Levocetirizine Dihydrochloride | 62 | $682 |
| Montelukast Sodium | 69 | $623 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 44 | $340 |
| Clindamycin Hcl | 19 | $293 |
| Mupirocin | 20 | $204 |
| Pantoprazole Sodium | 16 | $192 |
| Levothyroxine Sodium | 33 | $183 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in West Plains
- Talon ManingasJoplin$314K
- Ryan JacksonSaint Louis$284K
- Ravindra UppaluriSaint Louis$168K
- James GouldFestus$143K
- John SchneiderSaint Louis$74K
- Amit WaliaSaint Louis$21K
- Bharat PanugantiSaint Louis$19K
- Jeffrey SharonSt. Louis$18K
- Kelvin WallsLees Summit$14K
- Cristine Klatt-CromwellSaint Louis$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.